Morgan Stanley Upgrades Elanco Animal Health to Overweight, Announces $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Erin Wright has upgraded Elanco Animal Health (NYSE:ELAN) from Equal-Weight to Overweight and set a price target of $16. This upgrade suggests a positive outlook on Elanco's stock performance.
December 15, 2023 | 10:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Elanco Animal Health has been upgraded by Morgan Stanley from Equal-Weight to Overweight with a new price target of $16, indicating a positive future performance.
Analyst upgrades typically lead to a positive short-term reaction in the stock market as they suggest improved future performance and investor confidence. The new price target of $16 by Morgan Stanley is likely to set a bullish tone for Elanco's stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100